ExL is excited to release the agenda for the AI Innovations for Life Science Summit West, taking place November 6–7 in San Francisco. From early R&D to commercialization, our speaking faculty will dive into examples of how artificial intelligence is being used by drug development and device companies to accelerate various processes within their value chain.
Featured Speakers
Kevin Hua, Senior Manager A.I./Machine Learning Development, BAYER
Irene Choi, Director, Drug Discovery, VERGE GENOMICS
Charles Wolfus, Vice President, Digital Health and Business Operations, MYOKARDIA
Aris Persidis, President, BIOVISTA
David Klein, Co-Founder and CEO, CLICK THERAPEUTICS
Ram Josyula, Master Black Belt Coach and AI Consultant, BRISTOL-MYERS SQUIBB
While systems and platforms have been developed to transform several stages of the drug development life cycle, the industry is becoming more demanding of real-world examples of how ML is applied across the biomedical landscape. This event is the industry’s premier platform for those who are interested in optimizing the drug and device commercialization life cycle with an artificial intelligence system.
Featured Speakers
Kevin Hua, Senior Manager A.I./Machine Learning Development, BAYER
Irene Choi, Director, Drug Discovery, VERGE GENOMICS
Charles Wolfus, Vice President, Digital Health and Business Operations, MYOKARDIA
Aris Persidis, President, BIOVISTA
David Klein, Co-Founder and CEO, CLICK THERAPEUTICS
Ram Josyula, Master Black Belt Coach and AI Consultant, BRISTOL-MYERS SQUIBB
While systems and platforms have been developed to transform several stages of the drug development life cycle, the industry is becoming more demanding of real-world examples of how ML is applied across the biomedical landscape. This event is the industry’s premier platform for those who are interested in optimizing the drug and device commercialization life cycle with an artificial intelligence system.
